Showing results (31-40 of 69) with videos related to
Sort By:
Pageof 7
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 27, 2024
36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIOMichael J Bloch, Ajay J Kirtane, Michel Azizi, et al.JAMA|September 10, 2023
Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical TrialLuke J Laffin, David Rodman, James M Luther, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 1, 2022
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trialFlorian Rader, Ajay J Kirtane, Yale Wang, et al.JAMA|May 28, 2025
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical TrialAkshay S Desai, Adam D Karns, Jolita Badariene, et al.The Journal of Biological Chemistry|December 1, 2001
Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzymeDavid Fulton, Jason Fontana, Grzegorz Sowa, et al.Circulation Research|April 15, 2006
Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertensionChristophe Guignabert, Mohamed Izikki, Ly Ieng Tu, et al.Journal of the American College of Cardiology|April 22, 2026
Oral PCSK9 Inhibitor Enlicitide Versus Oral Nonstatin Therapies: A Phase 3 Randomized Clinical TrialAlberico L Catapano, Elina Mikhailova, Ann Marie Navar, et al.The Lancet. Respiratory Medicine|June 29, 2014
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trialMichael P Boyle, Scott C Bell, Michael W Konstan, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 22, 2020
Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion CatheterStefan Bertog, Alok Sharma, Felix Mahfoud, et al.Journal of Hypertension|August 26, 2021
Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trialNaomi D L Fisher, Ajay J Kirtane, Joost Daemen, et al.Pageof 7